文献速递白内障与屈光手术

自动定制光线追踪引导与波前优化LASIK的前瞻性同体对照比较

Prospective Intraindividual Comparison of Automated Customized Ray-Tracing-Guided versus Wavefront-Optimized LASIK.
PubMed 文献 · Ophthalmology · 2025-06-05

这项前瞻性、干预性、随机、双盲、对侧眼对照研究纳入30例(60眼)近视及近视散光患者,一眼行光线追踪引导LASIK(wavelight plus),对侧眼行波前优化LASIK。术后3个月,wavelight plus组等效球镜在±0.50 D内的眼比例为100%,波前优化组为90.0%,非劣效检验P<0.001;两组视力结果相当。

要点

  • 术后3个月等效球镜在±0.50 D内:wavelight plus组100% vs 波前优化组90.0%,非劣效P<0.001。
  • 等效球镜在±0.25 D内:wavelight plus组83.3% vs 波前优化组76.7%,非优效P=0.625。
  • wavelight plus平均等效球镜-0.05±0.21 D,波前优化组-0.16±0.23 D(P=0.039)。

核心结论

  • 自动光线追踪引导的wavelight plus LASIK安全性和有效性高,视力结果与波前优化LASIK相当。
  • 无需显然验光,wavelight plus即获得非劣效的屈光结果,且等效球镜准确度略高。

研究设计与样本

  • 前瞻性、干预性、随机、双盲、对侧眼对照研究。
  • 纳入30例(60眼)近视及近视散光患者,一眼行wavelight plus,对侧眼行波前优化LASIK。
  • wavelight plus的切削方案由光线追踪自动计算,仅使用单一诊断设备获得的客观测量。
  • 波前优化LASIK按显然验光规划治疗。
  • 主要终点为术后3个月等效球镜在±0.50 D内的眼比例,检验wavelight plus的非劣效性。

主要发现

  • 术后3个月等效球镜在±0.50 D内:wavelight plus组100%(95%CI 88.6-100)vs 波前优化组90.0%(95%CI 74.4-96.5),非劣效P<0.001。
  • 等效球镜在±0.25 D内:wavelight plus组83.3%(95%CI 66.4-92.7)vs 波前优化组76.7%(95%CI 59.1-88.2),非优效P=0.625。
  • 平均等效球镜:wavelight plus组-0.05±0.21 D vs 波前优化组-0.16±0.23 D(P=0.039)。
  • 两组柱镜和等效球镜绝对值相似(P>0.05)。
  • 单眼裸眼远视力:wavelight plus组-0.11±0.07 logMAR vs 波前优化组-0.09±0.09 logMAR,矫正远视力-0.14±0.05 logMAR vs -0.13±0.06 logMAR(P>0.05)。

关键数值与推荐

  • 主要终点非劣效性检验:wavelight plus组等效球镜在±0.50 D内100% vs 波前优化组90.0%,P<0.001。
  • 等效球镜在±0.25 D内非优效性检验:wavelight plus组83.3% vs 波前优化组76.7%,P=0.625。
  • 平均等效球镜:wavelight plus组-0.05±0.21 D vs 波前优化组-0.16±0.23 D,P=0.039。

临床怎么用

  • 原文结论认为wavelight plus安全性和有效性高,视力结果与波前优化LASIK相当。
  • 原文指出wavelight plus无需显然验光即获得非劣效屈光结果,等效球镜准确度略高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare automated customized ray-tracing-guided LASIK with wavefront-optimized LASIK by assessing intraindividual refractive and visual acuity outcomes. DESIGN: Prospective, interventional, randomized, double-blinded, contralateral-eye comparison. PARTICIPANTS: Thirty patients (60 eyes) with myopia and myopic astigmatism. METHODS: Ray-tracing-guided LASIK, termed "wavelight plus" (Alcon), was performed in 1 eye and wavefront-optimized LASIK in the fellow eye. For wavelight plus, the ablation profile was calculated automatically by ray-tracing, using only objective measurements obtained with a single diagnostic device. The manifest refraction was used for planning wavefront-optimized LASIK treatment. MAIN OUTCOME MEASURES: Manifest refraction spherical equivalent (MRSE), refractive cylinder, uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), and safety and efficacy indices were analyzed. The primary end point was the percentage of eyes with an MRSE within ±0.50 diopters (D) at 3 months, tested for noninferiority of wavelight plus. RESULTS: At 3 months after wavelight plus and wavefront-optimized LASIK, MRSE was within ±0.50 D in 100% (95% confidence interval [CI], 88.6-100) and 90.0% (95% CI, 74.4-96.5) of eyes and within ±0.25 D in 83.3% (95% CI, 66.4-92.7) and 76.7% (95% CI, 59.1-88.2) of eyes, respectively (wavelight plus noninferior for ±0.50 D, P < 0.001; nonsuperior for ±0.25 D, P = 0.625). The mean (± standard deviation) MRSE was -0.05 ± 0.21 D after wavelight plus and -0.16 ± 0.23 D after wavefront-optimized LASIK (P = 0.039). Refractive cylinder and absolute MRSE were similar after both treatments (P > 0.05). The mean monocular UDVA was -0.11 ± 0.07 logarithm of the minimum angle of resolution (logMAR) and -0.09 ± 0.09 logMAR, and the monocular CDVA was -0.14 ± 0.05 logMAR and -0.13 ± 0.06 logMAR after wavelight plus and wavefront-optimized treatments, respectively (P > 0.05). The UDVA was ≥20/20 in 100% (95% CI, 88.6-100) and 93.3% (95% CI, 78.7-98.2) of eyes, and ≥20/16 in 83.3% (95% CI, 66.4-92.7) and 73.3% (95% CI, 55.6-85.8%) of eyes after wavelight plus and wavefront-optimized LASIK, respectively. The efficacy index was 1.01 ± 0.14 and 0.98 ± 0.16, and the safety index was 1.08 ± 0.13 and 1.07 ± 0.14 for wavelight plus and wavefront-optimized LASIK, respectively (P > 0.05). CONCLUSIONS: The automated ray-tracing-guided LASIK treatment wavelight plus had a high safety and efficacy, with visual acuity outcomes comparable to those after wavefront-optimized LASIK. Without the need of manifest refraction, wavelight plus achieved noninferior refractive outcomes and a slightly higher accuracy in MRSE. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Khoramnia R, Naujokaitis T, Blöck L, et al. Prospective Intraindividual Comparison of Automated Customized Ray-Tracing-Guided versus Wavefront-Optimized LASIK. Ophthalmology. 2025. PMID: 40482723. doi:10.1016/j.ophtha.2025.05.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。